First Time Loading...

WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 19.96 HKD -4.95% Market Closed
Updated: Mar 5, 2024

Wall Street
Price Targets

Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WuXi Biologics (Cayman) Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 53.6 HKD with a low forecast of 22.22 HKD and a high forecast of 121.13 HKD.

Lowest
Price Target
22.22 HKD
11% Upside
Average
Price Target
53.6 HKD
169% Upside
Highest
Price Target
121.13 HKD
507% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
A
Agilent Technologies Inc
2% Downside
ILMN
Illumina Inc
14% Upside
BROOKS
Brooks Laboratories Ltd
57% Downside
1SXP
SCHOTT Pharma AG & Co KgaA
12% Downside
PPGN
PolyPeptide Group AG
24% Upside
688315
Novogene Co Ltd
132% Upside
WST
West Pharmaceutical Services Inc
14% Upside
HVO
hVIVO PLC
35% Upside

Revenue
Forecast

Revenue Estimate
WuXi Biologics (Cayman) Inc

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 60%. The projected CAGR for the next 4 years is 21%.

60%
Past Growth
21%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
WuXi Biologics (Cayman) Inc

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 85%. The projected CAGR for the next 4 years is 24%.

85%
Past Growth
24%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
WuXi Biologics (Cayman) Inc

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 93%. The projected CAGR for the next 4 years is 19%.

93%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
53.6 HKD

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 53.6 HKD with a low forecast of 22.22 HKD and a high forecast of 121.13 HKD.

What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
21%

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 60%. The projected CAGR for the next 4 years is 21%.

What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
24%

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 85%. The projected CAGR for the next 4 years is 24%.

What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 93%. The projected CAGR for the next 4 years is 19%.